Glenmark acquires Acetylcysteine injection, launches in US market

Glenmark Pharmaceuticals Ltd acquired the generic version of Acetylcysteine injection from Aspen Pharma USA Inc and launched it in the US market. The injection is used to treat acetaminophen overdose and is expected to have the same therapeutic effect as the listed drug Acetadote Injection.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ghFB3pL
via IFTTT